CervoMed Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy CervoMed Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for CervoMed Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for CervoMed Inc. is CRVO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
CervoMed Inc. has its primary listing on NASDAQ (Small cap). You can trade CervoMed Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, CervoMed Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include CervoMed Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like CervoMed Inc..